Implantable cardioverter-defibrillator therapy candidacy for patients with prior myocardial infarction and reduced ejection fraction remains unclear, with several factors influencing the decision.
This paper discusses the factors influencing the decision to use implantable cardioverter-defibrillator therapy in patients with prior myocardial infarction and reduced ejection fraction.
Absolute Event Rate: 0% vs 0%
Patients with a history of myocardial infarction and a reduced ejection fraction are at increased risk for life-threatening ventricular arrhythmias. Which of these patients are the most appropriate candidates for implantable cardioverter–defibrillator (ICD) therapy is unclear. Factors influencing the decision are discussed.
Robert J. Myerburg (Wed,) reported a other. Implantable cardioverter-defibrillator therapy candidacy for patients with prior myocardial infarction and reduced ejection fraction remains unclear, with several factors influencing the decision.